124 related articles for article (PubMed ID: 6809030)
21. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
23. Electron-beam therapy for mycosis fungoides: the Stanford University experience.
Hoppe RT; Cox RS; Fuks Z; Price NM; Bagshaw MA; Farber EM
Cancer Treat Rep; 1979 Apr; 63(4):691-700. PubMed ID: 109207
[TBL] [Abstract][Full Text] [Related]
24. A case of advanced mycosis fungoides with comprehensive skin and visceral organs metastasis: sensitive to chemical and biological therapy.
Liu YQ; Zhu WY; Shu YQ; Gu YH
Asian Pac J Trop Med; 2012 Aug; 5(8):669-72. PubMed ID: 22840460
[TBL] [Abstract][Full Text] [Related]
25. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
Vonderheid EC; Van Scott EJ; Wallner PE; Johnson WC
Cancer Treat Rep; 1979 Apr; 63(4):681-9. PubMed ID: 109206
[TBL] [Abstract][Full Text] [Related]
26. Treatment of cutaneous T cell lymphoma: current status and future directions.
Apisarnthanarax N; Talpur R; Duvic M
Am J Clin Dermatol; 2002; 3(3):193-215. PubMed ID: 11978140
[TBL] [Abstract][Full Text] [Related]
27. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy.
Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM
Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
Kaye FJ; Bunn PA; Steinberg SM; Stocker JL; Ihde DC; Fischmann AB; Glatstein EJ; Schechter GP; Phelps RM; Foss FM
N Engl J Med; 1989 Dec; 321(26):1784-90. PubMed ID: 2594037
[TBL] [Abstract][Full Text] [Related]
29. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
[TBL] [Abstract][Full Text] [Related]
30. Extracutaneous mycosis fungoides.
Merlo CJ; Hoppe RT; Abel E; Cox RS
Cancer; 1987 Aug; 60(3):397-402. PubMed ID: 3594377
[TBL] [Abstract][Full Text] [Related]
31. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
Wu PA; Huang V; Bigby ME
Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
[TBL] [Abstract][Full Text] [Related]
32. Combined therapy for patients with mycosis fungoides.
Griem ML; Tokars RP; Petras V; Variakojis D; Baron JM; Griem SF
Cancer Treat Rep; 1979 Apr; 63(4):655-7. PubMed ID: 109205
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
Dummer R; Foss F; Dreno B; Bagot M
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
[TBL] [Abstract][Full Text] [Related]
34. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
35. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
36. [A case of cutaneous T cell lymphoma improved with local administration of tumor necrosis factor].
Takahashi M; Mogi Y; Goto Y; Tsushima N; Takahashi Y; Fujikawa K; Watanabe N; Kohgo Y; Sugiyama S; Niitsu Y
Rinsho Ketsueki; 1989 Dec; 30(12):2152-6. PubMed ID: 2621796
[TBL] [Abstract][Full Text] [Related]
37. Prolonged initial remission in patients with nodular mixed lymphoma.
Longo DL; Young RC; Hubbard SM; Wesley M; Fisher RI; Jaffe E; Berard C; DeVita VT
Ann Intern Med; 1984 May; 100(5):651-6. PubMed ID: 6370065
[TBL] [Abstract][Full Text] [Related]
38. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
[TBL] [Abstract][Full Text] [Related]
39. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
40. The radiation therapy of early stage cutaneous T-cell lymphoma.
Micaily B; Moser C; Vonderheid EC; Koprowski C; Lightfoot D; Markoe A; Brady L
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1333-9. PubMed ID: 1695214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
